Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2024

Apr 25, 2024

3535_iss_2024-04-25_ffb48921-da0f-4e44-a400-d41ee03b893a.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Varming Holding AS
2 Reason for the notification
a) Position/status Close associate of CFO Jan Varming
b) Initial notification/
Amendment
Initial notification
3 Details of the issuer
a) Name Aqua Bio Technology ASA
b) LEI 5967007LIEEXZXGGEO44
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial Shares of Aqua Bio Technology ASA
instrument, type of instrument
Identification code ISIN: 0010307135
b) Nature of the transaction New shares to settle the share element of an earn-out pursuant
to an agreement dated 28 June 2022 and an amendment
agreement dated 23 April 2024.
c) Price(s) and volume(s) Price(s) Volume(s)
8.20 4,976,704
d) Aggregated information
A total of 4,976,704 shares, each at a subscription price of NOK
8.20, corresponding to a total subscription amount of NOK
-
Aggregated volume
-
Price
38,613,267, to be settled through debt conversion by way of-set
off.
e) Date of the transaction 23 April 2024
f) Place of the transaction Outside of trading venue
MIC: XOFF

Notification and public disclosure of transactions by Primary Insiders and their Close Associates